Surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease Dec. 26, 2022 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoConcomitant tricuspid repair in patients with degenerative mitral regurgitationVideoIncidence and burden of tricuspid regurgitation in patients with atrial fibrillationArticleTricuspid regurgitation impact on outcomes (TRIO): A simple clinical risk score VID-20544817 Medical Professionals Surgical management of transvenous lead-induced tricuspid regurgitation in adult and pediatric patients with congenital heart disease